News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Insight Genetics Awarded New National Cancer Institute Contract To Identify Resistance Mutations In Lung Cancer Patients



1/8/2014 9:20:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NASHVILLE, Tenn.--(BUSINESS WIRE)--Insight Genetics, Inc. today announced it has received a new $1.5 million Phase II Small Business Innovation Research (SBIR) contract from the National Cancer Institute (NCI). A continuation of a Phase I contract NCI awarded to Insight Genetics in 2011, the new contract will allow the company to continue its development of Insight ALK Resistanceā„¢, a diagnostic test that helps clinicians monitor their non-small cell lung cancer (NSCLC) patients for resistance to their prescribed cancer therapy.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES